Comparative efficacy of pegylated interferons alpha-2a and 2b in the treatment of HBeAg-negative chronic Hepatitis B infection

Karabay O., Tuna N., Esen Ş.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, cilt.24, sa.11, ss.1296-1301, 2012 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 24 Sayı: 11
  • Basım Tarihi: 2012
  • Doi Numarası: 10.1097/meg.0b013e328356eac2
  • Dergi Adı: EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1296-1301
  • Anahtar Kelimeler: chronic hepatitis B, pegylated interferon, treatment, E-ANTIGEN, PEGINTERFERON ALPHA-2A, HBSAG LOSS, VIRUS, THERAPY, EPIDEMIOLOGY, COMBINATION, LAMIVUDINE, GENOTYPES, TURKEY
  • Ondokuz Mayıs Üniversitesi Adresli: Evet

Özet

Introduction Interferons, pegylated interferons (PegIFN), and oral antivirals are used in the treatment of chronic hepatitis B (CHB) virus infection. The number of studies comparing the efficacy of PegIFNs in the treatment of HBe antigen-negative CHB is rather limited. In this trial, the efficacy of two PegIFN products used in the treatment of CHB is compared.